Sector – The Future of Our Profession
- Announcement: Summary of professional services in 6CPAThe Pharmaceutical Society of Australia welcomes the signing of the Sixth Community Pharmacy Agreement. It brings surety to the community pharmacy sector after a period of uncertainty for the whole profession.
- Snapshot 2017
Australians are missing out on evidence-based pharmacist care. Despite positive gains made in recent years, there is evidence to suggest that Australian consumers, particularly those with chronic and complex conditions, and those in rural and remote areas are missing out on evidencebased pharmacist services.
- Early Career Pharmacist White Paper
The Early Career Pharmacist (ECP) White Paper has been developed following national consultation among ECPs and pharmacy leaders.
- PSA’s Response to the Review of Pharmacy Remuneration and Regulation Interim Report 2017
The Review of Pharmacy Remuneration and Regulation presents an opportunity to explore innovative and sustainable ways pharmacists can contribute to Australia’s health system and optimise healthcare into the future.
- Position Statement: Screening & risk assessment
PSA recognises the important contribution pharmacists make to preventive care, including screening and risk assessment.
- Early Career Pharmacist Green Paper
The Early Career Pharmacist (ECP) Green Paper has been developed by PSA’s ECP Working Group as the first step in the process to determine a comprehensive, practical and sustainable long-term plan for ECPs to have successful and satisfying careers, while making significant contributions to Australia’s healthcare system.
- Fact Check – General Practice pharmacists in Australia
The peak national body for pharmacists, the Pharmaceutical Society of Australia (PSA) has strongly advocated and led calls for the integration of pharmacists in general practice clinics to boost healthcare outcomes for all Australians.
- Mental Health Care Framework
In response to opportunities arising from the Australian Government’s mental health reform agenda, the Pharmaceutical Society of Australia (PSA) has developed A framework for pharmacists as partners in mental health care (the ‘Framework’) in partnership with mental health consumers and carers, care coordinators, mental health policy and practice experts, pharmacists, general practitioners, psychiatrists, psychologists and mental health nurses.
- Submission: Response to the 2014 competition policy review issues paper June 2014
The purpose of this paper is to outline the views of the Pharmaceutical Society of Australia (PSA) with respect to the current regulatory environment underpinning the community pharmacy sector in Australia.
- Postion Statement: Minimising harm from the inappropriate use of over the counter analgesics
Pharmacists play an important role in assisting consumers to appropriately manage their pain through the provision of over the counter (OTC) analgesics in accordance with Quality Use of Medicines (QUM) principles.